ZEB2 and non-small cell lung carcinoma: It was also demonstrated in this cohort that ZEB2 expression had a strongly positive correlation with HAVCR2 (TIM-3) (R = 0.735), an immune checkpoint receptor that played a crucial role in regulating immune responses by promoting T cell exhaustion and limiting immune activation in NSCLC [Supplementary Figure 2].